# A Study to Assess Immunity to Specific Microbial Antigens in Healthy Smokers and Non-smokers and in Subjects With Stable COPD

> **NCT01516437** · NA · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 73 (actual)

## Conditions studied

- Respiratory Disorders

## Interventions

- **PROCEDURE:** Blood collection
- **PROCEDURE:** Swab collection
- **PROCEDURE:** Sputum collection

## Key facts

- **NCT ID:** NCT01516437
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02-01
- **Primary completion:** 2012-06-28
- **Final completion:** 2012-12-20
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2017-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01516437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01516437, "A Study to Assess Immunity to Specific Microbial Antigens in Healthy Smokers and Non-smokers and in Subjects With Stable COPD". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01516437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*